Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Xeridiem Medical Devices Inc. operates a patent portfolio in the Medical Devices & Mechanical Engineering technology area. The company currently has 1 pending office action. This prosecution is being conducted by 1 distinct examiner and is situated within 1 distinct art unit. This concentration shows that the company's current patenting efforts are focused on a single technical path, with all activity centralized under one examiner.
DIPERT, FORREST BLAKE is the busiest examiner for the portfolio, handling 1 pending office action. Since this is the only pending matter, the examiner's specific interpretation of Medical Devices & Mechanical Engineering standards will be the deciding factor for the company's current filings. For a practitioner, this means there is no examiner diversity to provide varied perspectives, making the specific feedback from DIPERT, FORREST BLAKE the primary guide for prosecution.
The involvement of only 1 distinct art unit further emphasizes the singular nature of the current prosecution. Success for Xeridiem Medical Devices Inc. depends on navigating the specific technical hurdles presented by the single examiner. With 1 pending office action, the company's immediate patent goals are tied to a single prosecution track, requiring a focused and tailored response to the examiner's requirements.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DIPERT, FORREST BLAKE | 1 | 50.0% | +64.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17463659 | FLUID MANAGEMENT CONNECTION SYSTEMS AND METHODS FOR MEDICAL DEVICES | DIPERT, FORREST BLAKE | 18d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17463659 | FLUID MANAGEMENT CONNECTION SYSTEMS AND METHODS FOR MEDICAL DEVICES | DIPERT, FORREST BLAKE | 18d overdue |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17463659 | FLUID MANAGEMENT CONNECTION SYSTEMS AND METHODS FOR MEDICAL DEVICES | DIPERT, FORREST BLAKE | 3783 | §102§103 | Non-Final OA | 18d overdue | Pending | Sep 01, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial